Vaidyanathan G, Affleck D J, Zalutsky M R
Department of Radiology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Bioconjug Chem. 1997 Sep-Oct;8(5):724-9. doi: 10.1021/bc9700502.
A conjugation method has been developed for the radioiodination of proteins which should be adaptable to kit formulation. m-Hydroxybenzoic acid was converted to 3-hydroxy-4-[131I]iodobenzoic acid in 65% radiochemical yield using Chloramine-T as the oxidant. This intermediate was then converted to N-succinimidyl 3-hydroxy-4-[131I]iodobenzoate ([131I]mSHIB) in 75% yield by reaction with N-hydroxysuccinimide and dicyclohexylcarbodiimide in a reaction time of only 10 min. Monoclonal antibody (mAb) 81C6 was labeled in 40-60% yield by reaction with [131I]mSHIB. Performing purifications of radioiodinated compounds using cartridges instead of HPLC did not alter conjugation efficiency, mAb immunoreactivity, or tissue distribution. Thyroid uptake of labeled mAb was low but up to 2.4 times higher than that seen when the mAb was labeled with N-succinimidyl 3-[125I]-iodobenzoate. These results suggest that [131I]mSHIB may be a useful reagent for the radioiodination of proteins, particularly in contexts when less complicated purification methods would be advantageous.
已开发出一种用于蛋白质放射性碘化的偶联方法,该方法应适用于试剂盒配方。使用氯胺-T作为氧化剂,间羟基苯甲酸以65%的放射化学产率转化为3-羟基-4-[¹³¹I]碘苯甲酸。然后,通过与N-羟基琥珀酰亚胺和二环己基碳二亚胺反应,在仅10分钟的反应时间内,将该中间体以75%的产率转化为N-琥珀酰亚胺基3-羟基-4-[¹³¹I]碘苯甲酸酯([¹³¹I]mSHIB)。单克隆抗体(mAb)81C6与[¹³¹I]mSHIB反应,标记产率为40%-60%。使用柱式净化法代替高效液相色谱法对放射性碘化化合物进行净化,不会改变偶联效率、单克隆抗体免疫反应性或组织分布。标记的单克隆抗体的甲状腺摄取率较低,但比用N-琥珀酰亚胺基3-[¹²⁵I]碘苯甲酸酯标记单克隆抗体时高出2.4倍。这些结果表明,[¹³¹I]mSHIB可能是一种用于蛋白质放射性碘化的有用试剂,特别是在不太复杂的净化方法更具优势的情况下。